Cannabis Therapy Corp. (CTCO) 0.9300 $CTCO
Cannabis Stocks Edge Higher Last Week Led by Nuvilex & Entertopia
ACCESSWIRE - Tue Jul 22, 8:32AM CDT
WHITEFISH, MT / July 22, 2014 / The Marijuana Index(TM) moved slightly higher last week, despite a 7% drop in GW Pharmaceuticals plc (NASDAQ: GWPH) shares. Medbox Inc. (OTC: MDBX), the second largest component of the index, also fell over 5% last week.
Cannabis Stocks Move Higher as Washington State Pot Sales Begin
ACCESSWIRE - Mon Jul 14, 8:30AM CDT
WHITEFISH, MT / July 14, 2014 / The Marijuana Index(TM) moved higher last week in the aggregate, despite a 13% drop in GW Pharmaceuticals plc (NASDAQ: GWPH) shares and a roughly 1.5% drop in Medbox Inc. (OTC: MDBX) shares, which comprise about half of the weighted index.
Cannabis Sativa & Easton Pharmaceuticals Led Cannabis Stocks Higher Last Week
ACCESSWIRE - Tue Jul 08, 8:07AM CDT
Whitefish, MT / July 8, 2014 / The Marijuana Index(tm) was mixed last week, as index heavyweights GW Pharmaceuticals plc (NASDAQ: GWPH) and Medbox Inc. (OTC: MDBX) gave up some of their earlier gains towards the end of the week.
Cannabis Therapy Corp. Commences Research to Support Development of New, Hemp-Based, Anti-Inflammatory Products
Marketwire - Tue Jul 08, 8:03AM CDT
Cannabis Therapy Corp. (OTCQB: CTCO) (the "Company"
, a development stage company aiming to become a leader in the research, development and commercialization of safe, all-natural, THC-free cannabinoid-based medicinal therapies and supplements (Nutraceuticals), is pleased to advise it is commencing exploratory laboratory research aimed at the development of cannabinoid-based products with potential application specific to inflammatory and auto-immune diseases.
Marijuana Sector Positioned to Move Higher as FDA Reviews Drug's Status
ACCESSWIRE - Mon Jun 30, 8:32AM CDT
WHITEFISH, MT / June 30, 2014 / The Marijuana Index(TM) traded marginally lower last week after MedBox Inc. (OTC: MDBX) and CannaVEST Corp.'s (OTC: CANV) moves lower offset GW Pharmaceuticals plc's (NASDAQ: GWPH) modest gains.
Cannabis Therapy Corp. Views FDA Reclassification Analysis as a Potential Win for Both Industry and Consumers
Marketwire - Mon Jun 30, 8:02AM CDT
Cannabis Therapy Corp. (OTCQB: CTCO) (the "Company" a development stage company aiming to become a leader in the research, development and commercialization of safe, all-natural, THC-free cannabinoid-based medicinal therapies and supplements (Nutraceuticals), is very pleased to note recent media reports that the U.S. Food and Drug Administration ("FDA" , at the request of the Drug Enforcement Administration ("DEA" , is conducting an analysis on whether the U.S. should downgrade the classification of marijuana as a Schedule 1 drug.
Cannabis Therapy Corp. Crop Management Advantage Accelerates Regional Farm Activity
Marketwire - Wed Jun 25, 8:03AM CDT
Cannabis Therapy Corp. (OTCQB: CTCO) (the "Company" a development stage company aiming to become a leader in the research, development and commercialization of safe, all-natural, THC-free cannabinoid-based medicinal therapies and supplements (Nutraceuticals), is pleased to advise that its initial crop of hemp cultivars is well underway with plants exhibiting normal healthy growth characteristics and a current height of approximately 16 inches.
Cannabis Therapy Uses Hemp to Shorten Time to Market
ACCESSWIRE - Mon Jun 23, 9:14AM CDT
WHITEFISH, MT / June 23, 2014 / Medical marijuana remains very controversial despite the favorable regulatory progress made over the past couple of years. While NORML polls suggest 80% of U.S. citizens support medical marijuana legalization, the remaining 20% represent a vocal minority that continue to campaign against it. Perhaps most importantly, the U.S. federal government still considers marijuana to be a Schedule I Controlled Substance.
Cannabis Therapy Pursues IP Strategy in Cannabis Industry
ACCESSWIRE - Wed Jun 18, 8:29AM CDT
Whitefish, MT / June 18, 2014 / Cannabis Therapy Corp (OTC: CTCO) a development stage company that aims to become a leader in the research, development, and commercialization of cannabinoid-based medicinal therapies and supplements, recently announced that it has selected international law firm Nixon Peabody LLP to manage and protect its current and future intellectual property assets.
Cannabis Therapy Corp. Engages Nixon Peabody LLP for IP Protection
Marketwire - Wed Jun 18, 1:27AM CDT
Cannabis Therapy Corp. (OTCQB: CTCO) (the "Company" , a development stage company aiming to become a leader in the research, development and commercialization of safe, all-natural, THC-free cannabinoid-based medicinal therapies and supplements (Nutraceuticals), has selected international law firm Nixon Peabody LLP to manage and protect its current and future intellectual property assets.
CannabisFN Weekly: Stocks Tread Water amid Regulatory Gains
ACCESSWIRE - Tue Jun 17, 1:00PM CDT
Whitefish, MT / June 17, 2014 / The Marijuana Index(tm) traded roughly even last week, although the sector remains well below its highs achieved earlier this year.
Cannabis Therapy Corp. CEO Conducts In-Depth Video Interview on CFN
Marketwire - Thu Jun 12, 8:02AM CDT
Cannabis Therapy Corp. (OTCQB: CTCO) (the "Company" a development stage company aiming to become a leader in the research, development and commercialization of safe, all-natural, THC-free cannabinoid-based medicinal therapies and supplements (Nutraceuticals), is very pleased to advise that its CEO, Dr. Soren Mogelsvang, recently conducted an in-depth video interview regarding the Company's goals and path to sustainability which is now available for review at http://bit.ly/1lkUK5l.
Cannabis Therapy Targets Low-Hanging Fruit with Experienced Team
ACCESSWIRE - Tue Jun 10, 8:38AM CDT
WHITEFISH, MT / June 10, 2014 / The U.S. cannabis industry grew 64% in 2013 and is expected to reach $2.34 billion by the end of 2014, according to ArcView Market Research. At the same time, the U.S. nutraceutical industry is projected to grow at a 5% CAGR to reach $75.9 billion by 2018, according to RNCOS. Cannabis Therapy (CTCO 0.96 1.05%) is executing its product development strategy to benefit from both of these trends, bringing biomedical methods and processes, as well as a seasoned management team, to the cannabis space.
CannabisFN Weekly: Canadian MMPRs Draw Closer to Commercialization
ACCESSWIRE - Mon Jun 09, 11:06AM CDT
Whitefish, MT / June 9, 2014 / The Marijuana Index(tm) was largely mixed over the past week following its tumble over the past three months.
Cannabis Therapy Corp. Applauds Measure to Limit Federal Interference at State Level
Marketwire - Mon Jun 09, 8:01AM CDT
Cannabis Therapy Corp. (OTCQB: CTCO) (the "Company" a development stage company aiming to become a leader in the research, development and commercialization of safe, all-natural, THC-free cannabinoid-based medicinal therapies and supplements (Nutraceuticals), is very pleased that the US House of Representatives passed a measure early on Friday May 30th that could prohibit the federal government from interfering with states' medical marijuana laws.
Cannabis Therapy Corp. Strategic Plan Featured on Cannabis Financial Network
Marketwire - Thu Jun 05, 8:03AM CDT
Cannabis Therapy Corp. (OTCQB: CTCO) (the "Company" , a development stage company aiming to become a leader in the research, development and commercialization of safe, all-natural, THC-free cannabinoid-based medicinal therapies and supplements (Nutraceuticals), wishes to advise that the Cannabis Financial Network ("CFN" recently initiated coverage of the Company with the publishing of a feature article titled "Cannabis Therapy Corp: Near-term Path to Market with Nutraceuticals," on June 3rd.
Cannabis Therapy Corp: Near-term Path to Market with Nutraceuticals
ACCESSWIRE - Tue Jun 03, 8:33AM CDT
WHITEFISH, MT / ACCESSWIRE / June 3rd, 2014 / The U.S. cannabis industry grew 64% in 2013 and is expected to reach $2.34 billion by the end of 2014, according to ArcView Market Research. With additional states expecting to legalize the drug over the next five years, the same group projects that the industry could hit $10.2 billion in size by 2018. These growth rates have attracted both public companies and investors to the space.
CannabisFN Weekly: Water Rights Could Become an Issue for Cannabis Growers
ACCESSWIRE - Tue May 27, 8:01AM CDT
Whitefish, MT / ACCESSWIRE / May 27, 2014 / The Marijuana Index™ moved modestly lower last week amid lackluster performance by bellwethers like GW Pharmaceuticals Ltd. (NASDAQ: GWPH) and CannaVEST Corp. (OTC: CANV), which traded down 0.88% and 69.5%, respectively.
Cannabis Therapy Secures Lease & Crop Management Services
ACCESSWIRE - Wed May 21, 8:05AM CDT
Whitefish, MT / May 21, 2014 / Cannabis Therapy Corp. (OTC: CTCO), a development-stage enterprise focused on manufacturing and marketing pharmaceutical level products containing phytocannabinoids for the treatment of various diseases and conditions, recently announced that it closed a commercial land lease and crop service agreement with Rocky Mountain Hemp Inc. of Springfield, Colorado.
CannabisFN Weekly: Stocks Mixed Despite Favorable Legalization Trends
ACCESSWIRE - Tue May 20, 8:36AM CDT
WHITEFISH, MT / May 20, 2014 / The Marijuana Index(TM) was mixed last week, moving higher mid-week and ending the week slightly negative. Large industry bellwethers like GW Pharmaceuticals plc (NASDAQ: GWPH) or CannaVEST Corp. (OTC: CANV) traded even or lower, while some smaller companies posted strong gains. Traders continue to approach the market with caution following another warning from FINRA.
Cannabis Stocks Edge Higher Last Week Led by Nuvilex & Entertopia
ACCESSWIRE - Tue Jul 22, 8:32AM CDT
WHITEFISH, MT / July 22, 2014 / The Marijuana Index(TM) moved slightly higher last week, despite a 7% drop in GW Pharmaceuticals plc (NASDAQ: GWPH) shares. Medbox Inc. (OTC: MDBX), the second largest component of the index, also fell over 5% last week.
Cannabis Stocks Move Higher as Washington State Pot Sales Begin
ACCESSWIRE - Mon Jul 14, 8:30AM CDT
WHITEFISH, MT / July 14, 2014 / The Marijuana Index(TM) moved higher last week in the aggregate, despite a 13% drop in GW Pharmaceuticals plc (NASDAQ: GWPH) shares and a roughly 1.5% drop in Medbox Inc. (OTC: MDBX) shares, which comprise about half of the weighted index.
Cannabis Sativa & Easton Pharmaceuticals Led Cannabis Stocks Higher Last Week
ACCESSWIRE - Tue Jul 08, 8:07AM CDT
Whitefish, MT / July 8, 2014 / The Marijuana Index(tm) was mixed last week, as index heavyweights GW Pharmaceuticals plc (NASDAQ: GWPH) and Medbox Inc. (OTC: MDBX) gave up some of their earlier gains towards the end of the week.
Cannabis Therapy Corp. Commences Research to Support Development of New, Hemp-Based, Anti-Inflammatory Products
Marketwire - Tue Jul 08, 8:03AM CDT
Cannabis Therapy Corp. (OTCQB: CTCO) (the "Company"
, a development stage company aiming to become a leader in the research, development and commercialization of safe, all-natural, THC-free cannabinoid-based medicinal therapies and supplements (Nutraceuticals), is pleased to advise it is commencing exploratory laboratory research aimed at the development of cannabinoid-based products with potential application specific to inflammatory and auto-immune diseases. Marijuana Sector Positioned to Move Higher as FDA Reviews Drug's Status
ACCESSWIRE - Mon Jun 30, 8:32AM CDT
WHITEFISH, MT / June 30, 2014 / The Marijuana Index(TM) traded marginally lower last week after MedBox Inc. (OTC: MDBX) and CannaVEST Corp.'s (OTC: CANV) moves lower offset GW Pharmaceuticals plc's (NASDAQ: GWPH) modest gains.
Cannabis Therapy Corp. Views FDA Reclassification Analysis as a Potential Win for Both Industry and Consumers
Marketwire - Mon Jun 30, 8:02AM CDT
Cannabis Therapy Corp. (OTCQB: CTCO) (the "Company"
a development stage company aiming to become a leader in the research, development and commercialization of safe, all-natural, THC-free cannabinoid-based medicinal therapies and supplements (Nutraceuticals), is very pleased to note recent media reports that the U.S. Food and Drug Administration ("FDA" , at the request of the Drug Enforcement Administration ("DEA" , is conducting an analysis on whether the U.S. should downgrade the classification of marijuana as a Schedule 1 drug. Cannabis Therapy Corp. Crop Management Advantage Accelerates Regional Farm Activity
Marketwire - Wed Jun 25, 8:03AM CDT
Cannabis Therapy Corp. (OTCQB: CTCO) (the "Company"
a development stage company aiming to become a leader in the research, development and commercialization of safe, all-natural, THC-free cannabinoid-based medicinal therapies and supplements (Nutraceuticals), is pleased to advise that its initial crop of hemp cultivars is well underway with plants exhibiting normal healthy growth characteristics and a current height of approximately 16 inches. Cannabis Therapy Uses Hemp to Shorten Time to Market
ACCESSWIRE - Mon Jun 23, 9:14AM CDT
WHITEFISH, MT / June 23, 2014 / Medical marijuana remains very controversial despite the favorable regulatory progress made over the past couple of years. While NORML polls suggest 80% of U.S. citizens support medical marijuana legalization, the remaining 20% represent a vocal minority that continue to campaign against it. Perhaps most importantly, the U.S. federal government still considers marijuana to be a Schedule I Controlled Substance.
Cannabis Therapy Pursues IP Strategy in Cannabis Industry
ACCESSWIRE - Wed Jun 18, 8:29AM CDT
Whitefish, MT / June 18, 2014 / Cannabis Therapy Corp (OTC: CTCO) a development stage company that aims to become a leader in the research, development, and commercialization of cannabinoid-based medicinal therapies and supplements, recently announced that it has selected international law firm Nixon Peabody LLP to manage and protect its current and future intellectual property assets.
Cannabis Therapy Corp. Engages Nixon Peabody LLP for IP Protection
Marketwire - Wed Jun 18, 1:27AM CDT
Cannabis Therapy Corp. (OTCQB: CTCO) (the "Company"
, a development stage company aiming to become a leader in the research, development and commercialization of safe, all-natural, THC-free cannabinoid-based medicinal therapies and supplements (Nutraceuticals), has selected international law firm Nixon Peabody LLP to manage and protect its current and future intellectual property assets. CannabisFN Weekly: Stocks Tread Water amid Regulatory Gains
ACCESSWIRE - Tue Jun 17, 1:00PM CDT
Whitefish, MT / June 17, 2014 / The Marijuana Index(tm) traded roughly even last week, although the sector remains well below its highs achieved earlier this year.
Cannabis Therapy Corp. CEO Conducts In-Depth Video Interview on CFN
Marketwire - Thu Jun 12, 8:02AM CDT
Cannabis Therapy Corp. (OTCQB: CTCO) (the "Company"
a development stage company aiming to become a leader in the research, development and commercialization of safe, all-natural, THC-free cannabinoid-based medicinal therapies and supplements (Nutraceuticals), is very pleased to advise that its CEO, Dr. Soren Mogelsvang, recently conducted an in-depth video interview regarding the Company's goals and path to sustainability which is now available for review at http://bit.ly/1lkUK5l. Cannabis Therapy Targets Low-Hanging Fruit with Experienced Team
ACCESSWIRE - Tue Jun 10, 8:38AM CDT
WHITEFISH, MT / June 10, 2014 / The U.S. cannabis industry grew 64% in 2013 and is expected to reach $2.34 billion by the end of 2014, according to ArcView Market Research. At the same time, the U.S. nutraceutical industry is projected to grow at a 5% CAGR to reach $75.9 billion by 2018, according to RNCOS. Cannabis Therapy (CTCO 0.96 1.05%) is executing its product development strategy to benefit from both of these trends, bringing biomedical methods and processes, as well as a seasoned management team, to the cannabis space.
CannabisFN Weekly: Canadian MMPRs Draw Closer to Commercialization
ACCESSWIRE - Mon Jun 09, 11:06AM CDT
Whitefish, MT / June 9, 2014 / The Marijuana Index(tm) was largely mixed over the past week following its tumble over the past three months.
Cannabis Therapy Corp. Applauds Measure to Limit Federal Interference at State Level
Marketwire - Mon Jun 09, 8:01AM CDT
Cannabis Therapy Corp. (OTCQB: CTCO) (the "Company"
a development stage company aiming to become a leader in the research, development and commercialization of safe, all-natural, THC-free cannabinoid-based medicinal therapies and supplements (Nutraceuticals), is very pleased that the US House of Representatives passed a measure early on Friday May 30th that could prohibit the federal government from interfering with states' medical marijuana laws. Cannabis Therapy Corp. Strategic Plan Featured on Cannabis Financial Network
Marketwire - Thu Jun 05, 8:03AM CDT
Cannabis Therapy Corp. (OTCQB: CTCO) (the "Company"
, a development stage company aiming to become a leader in the research, development and commercialization of safe, all-natural, THC-free cannabinoid-based medicinal therapies and supplements (Nutraceuticals), wishes to advise that the Cannabis Financial Network ("CFN" recently initiated coverage of the Company with the publishing of a feature article titled "Cannabis Therapy Corp: Near-term Path to Market with Nutraceuticals," on June 3rd. Cannabis Therapy Corp: Near-term Path to Market with Nutraceuticals
ACCESSWIRE - Tue Jun 03, 8:33AM CDT
WHITEFISH, MT / ACCESSWIRE / June 3rd, 2014 / The U.S. cannabis industry grew 64% in 2013 and is expected to reach $2.34 billion by the end of 2014, according to ArcView Market Research. With additional states expecting to legalize the drug over the next five years, the same group projects that the industry could hit $10.2 billion in size by 2018. These growth rates have attracted both public companies and investors to the space.
CannabisFN Weekly: Water Rights Could Become an Issue for Cannabis Growers
ACCESSWIRE - Tue May 27, 8:01AM CDT
Whitefish, MT / ACCESSWIRE / May 27, 2014 / The Marijuana Index™ moved modestly lower last week amid lackluster performance by bellwethers like GW Pharmaceuticals Ltd. (NASDAQ: GWPH) and CannaVEST Corp. (OTC: CANV), which traded down 0.88% and 69.5%, respectively.
Cannabis Therapy Secures Lease & Crop Management Services
ACCESSWIRE - Wed May 21, 8:05AM CDT
Whitefish, MT / May 21, 2014 / Cannabis Therapy Corp. (OTC: CTCO), a development-stage enterprise focused on manufacturing and marketing pharmaceutical level products containing phytocannabinoids for the treatment of various diseases and conditions, recently announced that it closed a commercial land lease and crop service agreement with Rocky Mountain Hemp Inc. of Springfield, Colorado.
CannabisFN Weekly: Stocks Mixed Despite Favorable Legalization Trends
ACCESSWIRE - Tue May 20, 8:36AM CDT
WHITEFISH, MT / May 20, 2014 / The Marijuana Index(TM) was mixed last week, moving higher mid-week and ending the week slightly negative. Large industry bellwethers like GW Pharmaceuticals plc (NASDAQ: GWPH) or CannaVEST Corp. (OTC: CANV) traded even or lower, while some smaller companies posted strong gains. Traders continue to approach the market with caution following another warning from FINRA.
